INTRODUCTION
Retinoids control cell differentiation and are transported by specific retinoid-binding proteins (Lotan, 1980; Chytil & Ong, 1984) . Cellular retinol-and retinoic acidbinding proteins (CRBP and CRABP respectively) are present in many tissues (Bashor et al., 1973; Sani & Hill, 1974; Ong & Chytil, 1978) and appear to be involved in the metabolism and/or biological functions of retinoids (Roberts & Sporn, 1984) . CRBP and CRABP have been isolated and characterized from tissue extracts by the following analytical methods: sucrose-gradient centrifugation (Sani & Hill, 1974) , h.p.l.c. analysis using ionexchange or size-exclusion chromatography (Bonelli & DeLuca, 1985; Shubeita et al., 1986) , polyacrylamide gel electrophoresis (Siegenthaler & Saurat, 1987) and dextran-charcoal adsorption (Trown et al., 1980) . A radioimmunoassay using polyclonal antibodies has been described for the quantification of these binding proteins (Ong et al., 1982) . Recently, nuclear receptors for RA (RA-inducible trans-activators) have been identified by recombinant-DNA techniques (Gigeure et al., 1987; Brand et al., 1988) .
The high affinity of CRABP for retinoic acid (RA) suggested that this retinoid immobilized on an insoluble matrix might function as an affinity adsorbent for the purification and characterization of CRABP. The synthesis and biological evaluation of several terminal bifunctional retinoids has been reported by Shealy et al. (1988) . As expected, those bifunctional analogues in which both terminal groups are ester or amide do not bind to CRABP. However, the bifunctional retinoids that have a free 14-carboxy group either trans (as in RA) or cis (as in 13-cis-RA) bind effectively to CRABP (Shealy et al., 1988) . The binding affinity ofthese retinoids for CRABP suggested their potential use as affinity adsorbents. It appeared a priori that the bifunctional retinoid ethyl 14-carboxyretinoate (Scheme 1, structure I) might be coupled to aminohexyl (AH)-Sepharose 4B through the 14-carboxy group. Alkaline hydrolysis of the protecting ester group of the coupled retinoid then provide an all-trans-RA unit attached covalently to the resin through an amide linkage formed between the 14-carboxy group of I and a primary amino group of AH-Sepharose 4B. The affinity resin has been obtained as postulated and has been shown to provide a rapid and efficient procedure for purifying CRABP from chickembryo skin and other tissues. Synthesis of 14-carboxy-13-cis-retinamide-Sepharose 4B Scheme 1 shows for synthesis of 14-carboxy-13-cisretinamide coupled to Sepharose 4B. Ethyl 14-carboxyretinoate (Shealy et al., 1988 ) (30 mg, purity 95 %) was dissolved in 1.5 ml of dioxan. The ligand solution was adjusted to 3000 dioxan with distilled water and the pH was adjusted to 4.5 with 1 M-HCl. AH-Sepharose 4B (2.5 g) was swelled in 0.5 M-NaCl for 15 min and washed repeatedly with water. A gel suspension (10 ml) was made in water with the pH adjusted to 4.5. The ligand solution was mixed with the gel suspension to give a final 2: 1 ratio (ligand/gel). The coupling reaction was started by slowly adding dropwise a solution (100 mg/ml) of EDC over a period of 15 min to give a final concentration of 0.1 M. The mixture was continuously rotated, the pH of slurry was maintained between 4.5 and 5.0 for the first 2 h, and the mixture was incubated overnight at room temperature. Any remaining activated sites on Sepharose were blocked by a further 3 h reaction with carbodiimide. The gel was thoroughly washed on a sintered-glass funnel with 30 % dioxan in water and with 30 % dioxan in sodium phosphate buffer, pH 7.2. The ester protecting group of 14-carboethoxy-13-cis-retinamide attached to Sepharose 4B (structure II) was then hydrolysed by alkali. Solid KOH was added to the gel suspension to achieve a 1: 1.25 molar ratio of ligand/KOH and the reaction was allowed to proceed for 2 h at 37°C, followed by 8-10 h at room temperature. Finally, the resin was washed extensively with water and equilibrated with 0.05 M-phosphate buffer, pH 7.2, containing 0.01 0 NaN3 for storage at 4 'C. The structure (III) of 14-carboxy-13-cis-retinamide-Sepharose 4B is shown in Scheme 1. All steps were performed under subdued light.
EXPERIMENTAL

Preparation of cytosol
The embryonic skin taken from 12-13 day-old chick embryos was homogenized in 3 vol. of TE; buffer (30 mmTris/HCl/ 1 mM-EDTA, pH 7.4), and the cytosolic frac-tion was obtained by ultracentrifugation at 105 000 g for 60 min at 4 'C. To achieve higher recovery and purification of CRABP, the cytosol was subjected to DEAESephadex (A-50), Sephadex G-100 or Affi-Gel Blue chromatography as described previously (Sani & Banerjee, 1978; Sani et al., 1980a) . In another experiment, the cytosol samples were treated with 10 mM-PHMB for 60 min at 4 'C, followed by incubation with 50 mM-DTT for 45 min. This protocol, as reported previously, caused the dissociation of RA-CRABP complexes and thus converted existing holo-CRABP into apo-CRABP (Shubeita et al., 1986; Sani et al., 1980a, b) . Cytosolic protein was determined by the method of Lowry et al. (1951) .
Purification of CRABP on affinity resin A Bio-Rad Econo column (1 cm x 10 cm) was packed with 7.5 ml of 14-carboxy-13-cis-retinamide-Sepharose 4B gel and equilibrated with 0.05 M-sodium phosphate buffer, 7.4. Partially purified cytosol samples (0.5-2 ml, 20 mg/ml) were loaded on the affinity column and washed with 50 ml of phosphate buffer containing 50 mM-NaCl (flow rate 1-2 ml/h). The elution was performed with 0.5 M-NaCl in 0.05 M-phosphate buffer, pH 6.0, and 0.5 ml fractions were collected. In pilot experiments, the elution profile of CRABP was monitored by using phosphate buffer containing 10 mM-PHMB or 0.5 mMNaSCN. The concentration of CRABP in various fractions was determined after incubation with [3H]RA by the dextran-charcoal method described below. All steps were done at 4 'C and in subdued light. After each affinity-chromatographic experiment, the resin was regenerated by washing with 1 M-NaCl in phosphate buffer, pH 7.4. The affinity column can be recycled at least six times without apparent loss of CRABP-binding capacity.
Measurement and analysis of CRABP
The concentration of CRABP in partially purified and affinity-purified preparations was determined by the dextran-charcoal assay. Aliquots (0.3 ml) were incubated with 150 pmol of [3H]RA overnight at 4 'C. Non-specific binding was measured in the presence of 200-fold molar excess of the ligand. Bound radioligand was separated from the free ligand by adding an equal volume of 2.5 % (w/v) dextran (T-70)-coated charcoal in phosphate buffer, 7.4, containing 0.1 % gelatin. After 10 min, the charcoal suspension was centrifuged, filtered through 0.22,m-pore-size filters (Gelman Acrodisc) and the radioactivity determined.
To determine the molecular mass of affinity-purified protein, samples (10-25,g), labelled with 150 pmol of [3H]RA in the absence or presence of 200-fold excess of ligand or pretreated with 2 mM-PHMB and 10 mM-DTT as described above, were applied to a gel-filtration column (Superose H-12, 10/30) equilibrated with 30 mmphosphate buffer, pH 7.4, containing 0.15 M-NaCl and attached to an automated f.p.l.c. system (flow rate 1 ml/min). Fractions (1 ml) were collected and the radioactivity was determined. Affinity-purified CRABP preparations were also analysed by vertical-10O% (w/v)-polyacrylamide-slab-gel electrophoresis in the presence of SDS according to Laemmli's (1971) 
RESULTS
A terminal bifunctional retinoid, ethyl 14-carboxyretinoate (Scheme 1, structure I), prepared by Shealy et al. (1988) , was used to synthesize an affinity resin for the purification and characterization of CRABP. This retinoid is an analogue of both ethyl all-trans-retinoate and 13-cis-RA. Through the action of a water-soluble carbodi-imide, an amide bond was formed between the free carboxy group of the retinoid and a primary amino group of AH-Sepharose 4B. The Sepharose-bound retinoid (structure II, Scheme 1) comprised both a 1 3-cisretinamide and an ethyl ester of all-trans-RA; the ester group was then hydrolysed in an alkaline medium. Thus a matrix was obtained in which all-trans-RA groups are attached covalently to the resin through an amide bond at position 14 (Scheme 1, structure Ill). With its free 14-carboxy group, this affinity resin (Fig. 1) would, therefore, act as a high-affinity ligand for CRABP. Although we have found that formation of all-trans-retinamides from all-trans-RA using carbodi-imides has resulted in less than 5 % isomerization of the 13-cis-isomers during the present coupling reaction, some isomerization at the C13=C'4 double bond could have occurred. However, this may not affect the CRABP-binding capacity of the resin, since both 13-cis-and all-trans-RA bind CRABP with approximately equal affinity (Sani & Hill, 1976) . Retention capacity of the affinity gel for CRABP The effectiveness of 14-carboxy-13-cis-retinamideSepharose 4B as an affinity matrix for CRABP binding was determined with partially purified cytosol preparations from chick-embryo skin. Partial purification of cytosol by gel-filtration, ion-exchange or Affi-Gel Blue chromatography was required before the affinity step for the removal of interfering proteins like serum albumin, which may interact with RA. Partially purified cytosol (15 ml; 1 mg/ml) was applied to a mini affinity column (1 ml) at a flow rate of 5 ml/h, and the flow-through fractions were assayed for [3H]RA-CRABP activity by the dextran-charcoal assay. The concentration of CRABP in the initial 1-15 flow-through fractions was reduced to 15 % of the totally loaded CRABP, indicating that the remaining 85% was retained on the affinity column (Fig. 1, curve A) . As more of the cytosol preparation was loaded on the column, the CRABP activity in the later fractions (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (Fig. 1, curve B) . In order to verify the requirement of apo-CRABP for binding to the resin, the cytosol was labelled with [3H]RA before application to the affinity column. Almost all of the [3H]RA-CRABP applied to the column was recovered in the initial flowthrough fractions (Fig. 1, curve C) . Thus the capacity of the affinity resin to bind CRABP depended on the ligand (RA), which, if prebound to protein (holo form), blocked its adsorption to the affinity column. This observation also suggested that CRABP (apo form) was bound selectively with high efficiency to 14-carboxy-13-cisretinamide gel. CRBP samples prelabelled with [3H]-retinol were not retained by the affinity column (results not shown). Elution of CRABP from the affinity column Several methods were tested for eluting the bound CRABP (from chick-embryo skin) from the affinity column. Elution with phosphate buffer, pH 7.4, containing 10 mM-PHMB was inefficient. However, 30-40 % of bound CRABP could be eluted with 0.5 M-NaCl/ phosphate buffer, pH 7.4. Most of the CRABP bound to the affinity resin was satisfactorily eluted by lowering the pH of the 0.5 M-NaCl/phosphate buffer from 7.4 to 6.0, the best yields obtained being between 0.3 and 0.9 mg of CRABP. An alternative elution method utilizing a chaotropic salt, 0.5 M-NaSCN, was also efficient; however, some loss of activity was noted (results not shown).
The elution profiles of proteins and CRABP measured after affinity chromatography of partially purified cytosol (20 mg/ml) are shown in Fig. 2 . The [3H]RA-binding activity in flow-through fractions possibly represented pre-existing holo-CRABP in the cytosol. Most of the other proteins were eluted from the column during sample application and subsequent washing with phosphate buffer, pH 7.4, containing 50 mM-NaCl. Up to 75 jug of CRABP was adsorbed per ml of affinity gel. Eluate fractions containing the maximum CRABP levels were Table 1 . Purification of CRABP from chick-embryo skin preparations Portions (0.3-0.5 ml) of CRABP were incubated with 150 pmol of [3H]RA in the absence or presence of 200-fold molar excess of RA overnight at 4°C and specific binding was determined by the dextran-charcoal assay (0.25 % dextran/2.5 % Norit A). CRABP from chick embryo was assessed on a Superose H-12 (gel-filtration) column attached to an f.p.l.c. system (Fig. 3) . A sharp peak of [3H]RA-CRABP radioactivity was observed in fractions 14-16, and its apparent native Mr was 15000. This radioactive peak was abolished in the presence of 200-fold molar excess of RA or by pretreatment of the cytosol with PHMB (Fig. 3) . This finding confirmed the ligand specificity of CRABP. The purity of CRABP from the affinity column was tested on discontinuous polyacrylamide slab gels under denaturing conditions. As shown in the inset to Fig. 3 , purified CRABP gave a major band, thus reflecting the high degree of purification (about 90 %). By using external standards, an M, of 15000 was obtained for the denatured protein. A minor band of Mr about 50000 was also observed in a few of the affinity-purified preparations.
DISCUSSION
In the present paper we have described the synthesis and application of 14-carboxy-13-cis-retinamideSepharose 4B, which is an affinity matrix bearing alltrans-RA moiety, and the use of this affinity resin to purify and characterize CRABP from chick-embryo skin. This affinity procedure provides several advantages: (i) 14-carboxy-13-cis-retinamide-Sepharose has high efficiency and selectivity for the RA-binding protein, (ii) the presence of an amide linkage between the ligand and the matrix makes this affinity resin relatively stable against cytosolic enzymes, and (iii) the affinity resin is easy to prepare.
Available procedures to isolate and determine CRBP and CRABP in tissue extracts include the classical sucrose-gradient analysis, h.p.l.c. size-exclusion chromatography and gel electrophoresis (Sani & Hill, 1974; Bonelli & DeLuca, 1985; Siegenthaler & Saurat, 1987) . These methods require the treatment and/or removal of free radioactive retinoid before analysis. The principal advantage of the present procedure of CRABP purification is the specificity of the affinity-chromatographic step using 14-carboxy-13-cis-retinamide-Sepharose 4B. In addition to high recovery and rapidity of purification, this affinity procedure affords CRABP having a purity of more than 90 %. Since the affinity material is specifically designed for CRABP, other proteins with similar M, values and charges, such as CRBP and fatty-acid-binding protein, do not bind to the affinity matrix.
The purification procedure described here was used to prepare about 1 mg of CRABP from 60-70 g of chickembryo skin. In this two-step protocol it is important to remove other RA-binding proteins, such as serum albumin, before the affinity step to achieve higher recovery and purity of CRABP. The degree of purification and recovery of CRABP by this method is comparable with those obtained by previously reported methods consisting of several separation steps (Ong & Chytil, 1978; Bonelli & DeLuca, 1985; Sani & Banerjee, 1978) . As judged from the results of polyacrylamide-gel electrophoresis and f.p.l.c. Superose analysis, the affinity-purified CRABP is close to electrophoretic homogeneity. It comigrates specifically with bound [3H]RA on a Superose column, and its Mr corresponds to 15000 reported by this and other laboratories (Sani & Banerjee, 1978; Ong & Chytil, 1978) . The conversion of holo-CRABP into apo-CRABP by PHM.J treatment (Shubeita et al., 1986; Sani et al., 1980a, b) and a possible involvement of an SH group in RA binding to CRABP are also confirmed by this affinity-chromatographic procedure.
In conclusion, a rapid and efficient affinitychromatographic method is now available which allows purification of CRABP from tissue extracts. Purification of the nuclear receptor(s) for RA (Giguere et al., 1987; Brand et al., 1988) by the use of this affinity gel is now required. Availability of pure CRABP and, possibly, nuclear receptor(s) by this procedure will be useful in studies dealing with the biological functions of these binding proteins.
